Literature DB >> 18620057

The immune system and cardiac repair.

Nikolaos G Frangogiannis1.   

Abstract

Myocardial infarction is the most common cause of cardiac injury and results in acute loss of a large number of myocardial cells. Because the heart has negligible regenerative capacity, cardiomyocyte death triggers a reparative response that ultimately results in formation of a scar and is associated with dilative remodeling of the ventricle. Cardiac injury activates innate immune mechanisms initiating an inflammatory reaction. Toll-like receptor-mediated pathways, the complement cascade and reactive oxygen generation induce nuclear factor (NF)-kappaB activation and upregulate chemokine and cytokine synthesis in the infarcted heart. Chemokines stimulate the chemotactic recruitment of inflammatory leukocytes into the infarct, while cytokines promote adhesive interactions between leukocytes and endothelial cells, resulting in transmigration of inflammatory cells into the site of injury. Monocyte subsets play distinct roles in phagocytosis of dead cardiomyocytes and in granulation tissue formation through the release of growth factors. Clearance of dead cells and matrix debris may be essential for resolution of inflammation and transition into the reparative phase. Transforming growth factor (TGF)-beta plays a crucial role in cardiac repair by suppressing inflammation while promoting myofibroblast phenotypic modulation and extracellular matrix deposition. Myofibroblast proliferation and angiogenesis result in formation of highly vascularized granulation tissue. As the healing infarct matures, fibroblasts become apoptotic and a collagen-based matrix is formed, while many infarct neovessels acquire a muscular coat and uncoated vessels regress. Timely resolution of the inflammatory infiltrate and spatial containment of the inflammatory and reparative response into the infarcted area are essential for optimal infarct healing. Targeting inflammatory pathways following infarction may reduce cardiomyocyte injury and attenuate adverse remodeling. In addition, understanding the role of the immune system in cardiac repair is necessary in order to design optimal strategies for cardiac regeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18620057      PMCID: PMC2642482          DOI: 10.1016/j.phrs.2008.06.007

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  358 in total

Review 1.  Concise review: stem cells, myocardial regeneration, and methodological artifacts.

Authors:  Piero Anversa; Annarosa Leri; Marcello Rota; Toru Hosoda; Claudia Bearzi; Konrad Urbanek; Jan Kajstura; Roberto Bolli
Journal:  Stem Cells       Date:  2006-11-22       Impact factor: 6.277

2.  Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche.

Authors:  Ramesh Mazhari; Joshua M Hare
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2007-02

3.  Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor.

Authors:  Soren Schenk; Niladri Mal; Amanda Finan; Ming Zhang; Matt Kiedrowski; Zoran Popovic; Patrick M McCarthy; Marc S Penn
Journal:  Stem Cells       Date:  2006-10-19       Impact factor: 6.277

4.  Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling.

Authors:  Pawel Zymek; Deuk-Young Nah; Marcin Bujak; Guofeng Ren; Anna Koerting; Thorsten Leucker; Peter Huebener; George Taffet; Mark Entman; Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2006-11-23       Impact factor: 10.787

Review 5.  The role of the thrombospondins in healing myocardial infarcts.

Authors:  Khaled Chatila; Guofeng Ren; Ying Xia; Peter Huebener; Marcin Bujak; Nikolaos G Frangogiannis
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2007-01

6.  Soluble TNF receptors prevent apoptosis in infiltrating cells and promote ventricular rupture and remodeling after myocardial infarction.

Authors:  Yoshiya Monden; Toru Kubota; Takaki Tsutsumi; Takahiro Inoue; Shunichi Kawano; Natsumi Kawamura; Tomomi Ide; Kensuke Egashira; Hiroyuki Tsutsui; Kenji Sunagawa
Journal:  Cardiovasc Res       Date:  2006-12-23       Impact factor: 10.787

Review 7.  The role of TGF-beta signaling in myocardial infarction and cardiac remodeling.

Authors:  Marcin Bujak; Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2006-10-07       Impact factor: 10.787

8.  The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response.

Authors:  Kurt Gritman; Donna M Van Winkle; Christina U Lorentz; Diane Pennica; Beth A Habecker
Journal:  Cytokine       Date:  2006-12-05       Impact factor: 3.861

Review 9.  Chemokines in ischemia and reperfusion.

Authors:  Nikolaos G Frangogiannis
Journal:  Thromb Haemost       Date:  2007-05       Impact factor: 5.249

10.  Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction.

Authors:  Yoshiya Monden; Toru Kubota; Takahiro Inoue; Takaki Tsutsumi; Shunichi Kawano; Tomomi Ide; Hiroyuki Tsutsui; Kenji Sunagawa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-04-06       Impact factor: 4.733

View more
  239 in total

Review 1.  Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.

Authors:  Wolfgang Poller; Madlen Rother; Carsten Skurk; Carmen Scheibenbogen
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Phenotypic and functional alterations on inflammatory peripheral blood cells after acute myocardial infarction.

Authors:  Tiago Carvalheiro; Isabel Velada; Ana Valado; Fernando Mendes; António Martinho; Natália António; Lino Gonçalves; Luís Providência; Maria Luísa Pais; Artur Paiva
Journal:  J Cardiovasc Transl Res       Date:  2012-04-21       Impact factor: 4.132

Review 3.  Optimizing dynamic interactions between a cardiac patch and inflammatory host cells.

Authors:  Donald O Freytes; Laura Santambrogio; Gordana Vunjak-Novakovic
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

4.  Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes.

Authors:  Raju V S R K Gottumukkala; HuiJuan Lv; Lizbeth Cornivelli; Amy J Wagers; Raymond Y Kwong; Roderick Bronson; Garrick C Stewart; P Christian Schulze; William Chutkow; Howard A Wolpert; Richard T Lee; Myra A Lipes
Journal:  Sci Transl Med       Date:  2012-06-13       Impact factor: 17.956

Review 5.  Genetic engineering of mesenchymal stem cells and its application in human disease therapy.

Authors:  Conrad P Hodgkinson; José A Gomez; Maria Mirotsou; Victor J Dzau
Journal:  Hum Gene Ther       Date:  2010-10-22       Impact factor: 5.695

6.  Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.

Authors:  Jing Huang; Zhiping Zhang; Jian Guo; Aiguo Ni; Arjun Deb; Lunan Zhang; Maria Mirotsou; Richard E Pratt; Victor J Dzau
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

Review 7.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

8.  Aging and Cardiac Fibrosis.

Authors:  Anna Biernacka; Nikolaos G Frangogiannis
Journal:  Aging Dis       Date:  2011-04       Impact factor: 6.745

9.  Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair.

Authors:  Shirley Dehn; Edward B Thorp
Journal:  FASEB J       Date:  2017-08-31       Impact factor: 5.191

10.  IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation.

Authors:  Mira Jung; Yonggang Ma; Rugmani Padmanabhan Iyer; Kristine Y DeLeon-Pennell; Andriy Yabluchanskiy; Michael R Garrett; Merry L Lindsey
Journal:  Basic Res Cardiol       Date:  2017-04-24       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.